Y-mAbs Therapeutics, Inc. Contracts & Agreements

48 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Equity Distribution Agreement, dated March 4, 2025, by and between Y-mAbs Therapeutics, Inc. and Oppenheimer & Co. Inc
Y-mAbs Therapeutics, Inc.
Biotechnology
2025
Amendment No.1 to License Agreement dated December 17, 2020, entered into and effective on December 9, 2024, by and between the Registrant and SciClone Pharmaceuticals...
Y-mAbs Therapeutics, Inc.
Biotechnology
2025
Amendment No.3 to License Agreement dated August 20, 2015, entered into and effective on November 8, 2024, by and between the Registrant and Memorial Sloan-Kettering Cancer Center
License Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2025
Description of the registrant's securities registered pursuant to section 12 of the Securities Exchange Act of 1934
Y-mAbs Therapeutics, Inc.
Biotechnology
2025
License Agreement dated September 11, 2024, by and between the Registrant and Princeton 202 Associates Limited Partnership
License Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2024
Lease Agreement dated September 11, 2024, by and between the Registrant and Princeton 202 Associates Limited Partnership
Lease Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
NJ
2024
License Agreement, entered into on October 29, 2024 and effective October 23, 2024, by and between Y-mAbs Therapeutics, Inc. and Nobelpharma Co., Ltd
License Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2024
Consultancy Agreement, entered into on July 16, 2024, between Investeringsselskabet GH ApS and the Company
Y-mAbs Therapeutics, Inc.
Biotechnology
2024
Separation Agreement, entered into on July 16, 2024, between Bo Kruse and Y-mAbs Therapeutics A/S
Separation Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2024
Employment Agreement, entered into on June 28, 2024, between Peter Pfreundschuh and the Company
Employment Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2024
Severance Agreement dated March 21, 2024 between Y-mAbs Therapeutics A/S and Steen Lisby
Severance Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2024
Amended and Restated Non-Employee Director Compensation Policy, effective April 26, 2024
Compensation Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2024
Form of Performance Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
DE
2024
Amendment to Employment Agreement for Dr. Vignesh Rajah, effective as of January 1, 2024
Employment Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2024
Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934
Y-mAbs Therapeutics, Inc.
Biotechnology
2024
Amendment, dated August 16, 2023, to Lease Agreement dated January 10, 2018, by and between the Registrant and RXR HB Owner LLC
Lease Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2023
Employee Confidential Information and Inventions Assignment Agreement, dated October 17, 2023, between Michael Rossi and the Company
Assignment Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2023
Employment Agreement, entered into on October 17, 2023, between Michael Rossi and the Company
Employment Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2023
Employment Agreement for Ms. Susan Smith, effective as of January 1, 2022
Employment Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2023
Non-Employee Director Compensation Policy, adopted on January 17, 2023
Compensation Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2023
Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934
Y-mAbs Therapeutics, Inc.
Biotechnology
2023
Form of Stock Option Grant Notice and Stock Option Agreement under the 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
DE
2022
Separation Agreement and General Release, effective as of September 22, 2022, between Y-mAbs Therapeutics, Inc. and Claus Juan Mller San Pedro
Separation Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2022
Form of Stock Option Grant Notice and Stock Option Agreement for directors under the 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
DE
2022
Form of Retention Bonus Agreement of Y-mAbs Therapeutics, Inc
Bonus & Incentive Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2022
Form of Retention Bonus Agreement of Y-mAbs Therapeutics A/S
Bonus & Incentive Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2022
Retention Bonus Agreement, dated May 30, 2022 by and between EVP and Chief Financial Officer, Bo Kruse and Y-mAbs Therapeutics A/S
Bonus & Incentive Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2022
Form of Stock Option Grant Notice and Stock Option Agreement under the 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
DE
2022
Amendment to Employment Agreement for Dr. Vignesh Rajah, effective as of March 10, 2021
Employment Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2022
Employment Agreement for Dr. Vignesh Rajah, effective as of June 2, 2020
Employment Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2022
Amendment to Employment Agreement for Dr. Steen Lisby, effective as of June 1, 2020
Employment Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2022
Employment Agreement for Dr. Steen Lisby, effective as of August 1, 2017
Employment Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2022
Amendment No. 2, dated March 18, 2021 to License Agreement, dated as of August 20, 2015 between Registrant and Memorial Sloan Kettering Cancer Center
License Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2022
Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934
Y-mAbs Therapeutics, Inc.
Biotechnology
2022
Amendment No. 1, dated March 18, 2021 to License Agreement, dated as of August 20, 2015 between Registrant and Memorial Sloan Kettering Cancer Center
License Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
2021
Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934
Y-mAbs Therapeutics, Inc.
Biotechnology
2021
Asset Purchase Agreement by and between Y-mAbs Therapeutics, Inc. and United Therapeutics Corporation dated December 24, 2020
Purchase Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
DE
2021
Underwriting Agreement, dated February 17, 2021, by and among Y-mAbs Therapeutics, Inc., and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and BofA Securities, Inc., as...
Underwriting Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2021
License Agreement dated December 17, 2020 between Y-mabs Therapeutics, Inc., and SciClone Pharmaceuticals International Ltd
License Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2020
Form of Stock Option Grant Notice and Stock Option Agreement under the 2018 Equity Incentive Plan (as amended, directors)
Bonus & Incentive Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
DE
2020
Form of Stock Option Grant Notice and Stock Option Agreement under the 2018 Equity Incentive Plan (as amended, employees, consultants and service providers other than directors)
Bonus & Incentive Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
DE
2020
Master Sponsored Research Agreement effective as of October 7, 2020 by and between the Company and Memorial Sloan Kettering Cancer Center
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2020
License Agreement, effective as of April 15, 2020, by and among the Company, Memorial Sloan Kettering Cancer Center and Massachusetts Institute of Technology
License Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2020
Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934
Y-mAbs Therapeutics, Inc.
Biotechnology
2020
Settlement and Assumption and Assignment of MSK License Agreement and Y-mAbs Sublicense Agreement, dated as of December 2, 2019, by and among the Company, MabVax Therapeutics...
Settlement Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2019
Y-mAbs Sublicense Agreement, dated as of June 27, 2018, by and between the Company and MabVax Therapeutics Holdings, Inc
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2019
Underwriting Agreement, dated October 29, 2019, by and among the Company and Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and BofA Securities, Inc., as representatives of...
Underwriting Agreements
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2019
Amended and Restated Sponsored Research Agreement effective as of September 13, 2019 by and between the Company and Memorial Sloan Kettering Cancer Center
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2019